This proposal is for the renewal of a highly successful Cooperative Hepatitis C Research Center that supports a multi-disciplinary program of investigation comprising three coordinated projects but interactive and complementary research aims. Each of the projects and the major research themes of the Center seek a better understanding of the host-virus interface. The research themes that bind the Center together include investigation of (1) the molecular virology of HCV and HCV-host cell interactions, and the establishment of highly permissive cell culture systems permitting the rescue of virus from synthetic RNA in vitro, (2) the cellular and whole organ response to HCV infection, including the application of high density oligonucleotide microarray expression analysis to a range of available HCV systems: cultured cells transfected with synthetic infectious RNA, HCV transgenic mice, and HCV-infected chimpanzees, and (3) viral and host factors controlling the establishment of persistent infection in experimentally infected chimpanzees, and (3) viral and host factors controlling the establishment of persistent infection in experimentally infected chimpanzees and acutely infected humans. The proposed studies thus extend from the cellular to the whole animal level, and include systems supporting efficient replication of HICV, and utilize modified infectious clones of HC to characterize viral and host cell determinants of replication. Microarray studies will investigated the impact of HCV proteins on gene expression in cells transfected with RNA, and assess gene expression in livers from HCV transgenic mice and experimentally infected chimpanzees. There are interconnected aims, wince well designed expression analyses will provide useful information concerning the nature of the restriction of HCV replication in cultured cells. Chimpanzee and human studies in Projects 2 and 3 focus on viral and host determinants of viral clearance and the critical early immune response to acute infection. An Administrative Core directs a robust Research Development Program supporting pilot research awards to investigators who are new to the field. The major projects are tightly interwoven so that advances in understanding HCV infection at the cellular level can be rapidly exploited to further understanding of disease at the level of the patient. This enhances the likelihood that knowledge arising from these studies will ultimately lead to improved control of this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI040035-09
Application #
6761814
Study Section
Special Emphasis Panel (ZAI1-LIG-M (M1))
Program Officer
Koshy, Rajen
Project Start
1996-08-01
Project End
2005-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
9
Fiscal Year
2004
Total Cost
$1,051,648
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Jarret, Abigail; McFarland, Adelle P; Horner, Stacy M et al. (2016) Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat Med 22:1475-1481
Hong, MeeAe; Schwerk, Johannes; Lim, Chrissie et al. (2016) Interferon lambda 4 expression is suppressed by the host during viral infection. J Exp Med 213:2539-2552
Yi, MinKyung; Hu, Fengyu; Joyce, Michael et al. (2014) Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol 88:3678-94
Li, Kui; Lemon, Stanley M (2013) Innate immune responses in hepatitis C virus infection. Semin Immunopathol 35:53-72
Wilkins, Courtney; Woodward, Jessica; Lau, Daryl T-Y et al. (2013) IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology 57:461-9
Horner, Stacy M; Park, Hae Soo; Gale Jr, Michael (2012) Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix ?0. J Virol 86:3112-20
Welsch, Christoph; Schweizer, Sabine; Shimakami, Tetsuro et al. (2012) Ketoamide resistance and hepatitis C virus fitness in val55 variants of the NS3 serine protease. Antimicrob Agents Chemother 56:1907-15
Zhou, Yan; Callendret, BenoƮt; Xu, Dan et al. (2012) Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. J Exp Med 209:1481-92
Grebely, Jason; Prins, Maria; Hellard, Margaret et al. (2012) Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis 12:408-14
Shimakami, Tetsuro; Yamane, Daisuke; Jangra, Rohit K et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 109:941-6

Showing the most recent 10 out of 156 publications